Nadja Scheibler

Nadja Scheibler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadja Scheibler has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Heiss

    Experimental Trauma Surgery, Faculty of Medicine, Justus-Liebig-University, 35392 Giessen, Germany

    1 shared publication
  • Christoph Biehl

    Experimental Trauma Surgery, Justus-Liebig-University of Giessen, Giessen, Germany

    1 shared publication
  • Deeksha Malhan

    Institute for Theoretical Biology (ITB), Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 10117 Berlin, Germany

    1 shared publication
  • Gero Knapp

    Department of Trauma, Hand and Reconstructive Surgery, Faculty of Medicine, Justus-Liebig-University of Giessen, 35392 Giessen, Germany

    1 shared publication
  • Markus Rupp

    Klinik und Poliklinik für Unfall‑, Hand- und Wiederherstellungschirurgie, Universitätsklinikum Gießen und Marburg GmbH, Gießen, Deutschland

    1 shared publication
  • Nike Walter

    Department for Psychosomatic Medicine, University Hospital Regensburg, Regensburg, Germany

    1 shared publication

Latest Publications

  • Open Access

    Mortality, Risk Factors and Risk Assessment after Periprosthetic Femoral Fractures—A Retrospective Cohort Study

    by Thaqif El Khassawna, Gero Knapp, Nadja Scheibler, Deeksha Malhan, Nike Walter, Christoph Biehl, Volker Alt, Christian Heiss, Markus Rupp

    Periprosthetic femoral fracture (PFF) is a devastating complication. Here, the authors aimed to determine the influence of the timing of surgery as a risk factor for mortality and poor postoperative outcome in patients suffering from PFF. A retrospective descriptive analysis of patients treated for PFF between January 2010 and March 2018 was performed. In addition to patient and treatment characteristics, we assessed mortality rates and postoperative functional outcome by using the Harris Hip and WOMAC score. One-year mortality after PFF was 10.7%. Delayed surgery after 48 h did not negatively influence mortality after PFF. The postoperative hospital stay did not influence the mortality rate, nor did it correlate with medical scores of comorbidities, general health or functionalities. Cementation of stem correlated negatively with the WOMAC score. Deceased patients had a higher Charlson Comorbidity Index (CCI) score, while American society of Anaesthesiologists (ASA) scores did not show a significant difference. There were no differences between ORIF and revision arthroplasty. In conclusion, delayed surgery after 48 h does not negatively influence mortality after PFF. The CCI seems to be a suitable tool to assess patients’ risk for increased mortality after PFF, while the usually used ASA score is not able to achieve a relevant risk assessment.